Sector News

UnitedHealth adds new C-suite member from Lockheed Martin

November 14, 2019
Life sciences

UnitedHealth Group Inc. has hired Patricia Lewis as its new chief human resources officer. She’ll serve in the office of the chief executive, the company said in an email. She’s replacing D. Ellen Wilson, who is retiring.

Previously, Lewis served in the same role at Lockheed Martin Corp. She’s also worked in human resources for IBM and DuPont.

At Lockheed Martin, Lewis had success starting a number of talent initiatives, including the STEM Scholarship Program and the Program Management Talent Initiative, with the goal of increasing the presence of traditionally underrepresented groups in STEM.

Lewis was recently featured in Politco’s “Women Rule” newsletter under the heading “Wisdom of the Week.” Her wisdom read, in part, “Bold leaders consistently demonstrate courage. Being courageous means taking risks even if you are faced with an uncertain outcome.”

UnitedHealth is Minnesota’s largest public company. In 2018, it had an income of $11.99 billion on $229.48 billion in sales. It employs 18,500 people in Minnesota alone, according to Business Journal research.

By: Carrigan Miller

Source: bizjournals.com

comments closed

Related News

May 15, 2022

Novo Nordisk and Flagship Pioneering announce a strategic collaboration to create a portfolio of transformational medicines

Life sciences

The companies will explore opportunities to apply Flagship’s innovative bioplatforms – an ecosystem that currently comprises 41 companies – to scientific challenges in disease areas within cardiometabolic and rare diseases and initiate research programmes based on these.

May 15, 2022

BD, Babson set sights on bringing simple blood collection into the home

Life sciences

BD is expanding its long-running partnership with the blood collection company Babson Diagnostics. The two companies have been working together since 2019 on a device that can gather small volumes of blood from the capillaries in the fingertip without requiring any specialized training, and beginning with a focus on supporting primary care in retail settings.

May 15, 2022

CSL’s $11.7B Vifor buy, 2021’s biggest biopharma M&A deal, hits antitrust delay

Life sciences

Wednesday, Australian biotech CSL said (PDF) the regulatory review of its $11.7 billion acquisition of Switzerland’s Vifor Pharma will take “a few more months,” suggesting it won’t be able to close the transaction by June 2022 as previously expected.